国际眼科杂志Issue(4)：633-636,4.DOI:10.3980/j.issn.1672-5123.2014.04.15
青光眼视神经保护的治疗现状及进展
Current approaches and advances in neuroprotection of glaucoma
摘要
Abstract
Glaucoma is aneurodegenerative disease characterized by loss of retinal ganglion cells and their axons.Recent evidence suggests that intraocular pressure ( IOP) is only one of the risk factors for glaucoma, and the disease progression continues in many patients, despite the IOP has been lowered effectively.This review summarized the latest advances in glaucoma neuroprotection, such as the pharmacological approaches, gene therapy, immunomodulators and vaccination, stem cell therapy, bioenergetics, and provided new outlook of neuroprotection therapy for glaucoma.关键词
青光眼/药物疗法/视神经保护/视网膜神经节细胞Key words
glaucoma/drug therapy/neuroprotection/retinal ganglion cell引用本文复制引用
胡倩倩,吴仁毅..青光眼视神经保护的治疗现状及进展[J].国际眼科杂志,2014,(4):633-636,4.基金项目
国家自然科学基金（ No．81170841）；厦门市科技计划杰出青年创新人才计划项目（ No．3502 Z20116011）@@@@National Natural Science Foundation of China （ No．81170841）；Science and Technology Project for Distinguished Youth of Xiamen （）
